GE Healthcare Breast Tomosynthesis Solution Gains CE Marking

share Share
GE Healthcare has announced CE marking for SenoClaire, GE’s new generation of breast tomosynthesis solution designed with a three-dimensional imaging technology. SenoClaire technology uses a low-dose short X-ray sweep around the positioned breast with nine exposures acquired with a “step-and-shoot” method, removing the potential motion from images.

“We are thrilled to receive the CE marking for this important product in our Women’s Health business. We continue to innovate our portfolio and aim to help clinicians expand care to more women globally in order to help reduce breast cancer. Our goal was to pioneer an upgrade solution for both our digital mammography platforms, Senographe* Essential and Senographe Care, providing flexibility for customers to enhance their clinical offering for their clinic and patient workflow,” said Prahlad Singh, General Manager, Women’s Health, GE Healthcare - Detection & Guidance Solutions (DGS).

With GE’s SenoClaire, powered by ASiRDBT a single MLO view provides clinical non-inferiority compared to a 2-view digital mammography exam—at half the dose and with just one compression. 

Source: GE Healthcare, 16 July 2013

Published on : Fri, 2 Aug 2013


Print as PDF

Related Articles

Growing number of peer-reviewed clinical publications document significant advantages of Hologic® tomosynthesis; Now, Hologic... Read more

GE Healthcare has issued a statement to announced that the somo•vTM INSIGHT System has been named category leader and awarded... Read more

Revolution CT to give clinicians a test that gives them outstanding image quality and reduced dose exposure for patients.GE Healthcare,... Read more

Tomosynthesis, GE GE Healthcare has announced CE marking for SenoClaire, GE’s new generation of breast tomosynthesis solution designed with a three-dimensional imaging tec

No comment


Please login to leave a comment...

Highlighted Products